Oncolytics Biotech, Inc. (ONCY)
Nasdaq: ONCY · Pharmaceutical Preparations · Calgary · filing with the SEC since 2002
Who runs Oncolytics Biotech, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Kelly Jared
Chief Executive Officer. First filing Jan 2026, latest Jun 3, 2026, 2 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
14 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kelly Jared | Chief Executive Officer | Jan 2026 | Jun 3, 2026 | none |
| Look Kirk | Chief Financial Officer | Jan 2026 | Jun 3, 2026 | none |
| Mcadory John Bearden | Chief Operating Officer | Jun 2026 | Jun 3, 2026 | none |
| Aromando Andrew | Chief Business Officer | Jan 2026 | Jun 3, 2026 | none |
| Hagerman Allison | Chief Technology Officer | Jan 2026 | Jun 3, 2026 | none |
| Heineman Thomas Charles | Chief Medical Officer | Jan 2026 | Jun 3, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Andrews Patricia S | director | Jan 2026 | Jun 3, 2026 | none |
| Brown Deborah Margaret | director | Jan 2026 | Jun 3, 2026 | none |
| Glover Stephen C. | director | Jun 2026 | Jun 3, 2026 | none |
| Holtham Angela | director | Jan 2026 | Jun 3, 2026 | none |
| Parsons James T. | director | Jan 2026 | Jun 3, 2026 | none |
| Pisano Wayne | director | Jan 2026 | Jun 3, 2026 | none |
| Rigby Jonathan | director | Jan 2026 | Jun 3, 2026 | none |
| Seizinger Bernd R. | director | Jan 2026 | Jun 3, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.